| Date | Form | Description | Docs | XBRL | Pages |
| 06/14/13 | EFFECT | Notice of Effectiveness |
|
1 | |
| 06/14/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 | |
| 06/14/13 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
16 | |
| 06/11/13 | UPLOAD | SEC-generated letter |
|
1 | |
| 05/28/13 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
6 | |
| 05/22/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/21/13 | UPLOAD | SEC-generated letter |
|
3 | |
| 05/21/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/10/13 | 8-K | Current report filing |
|
5 | |
| 05/03/13 | CT ORDER | Confidential treatment order |
|
1 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...